Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis A Farraye

Showing results (421-430 of 432) with videos related to

Pageof 44
Sort By:
The American Journal of Gastroenterology|January 14, 2022
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel DiseasesMichael D Kappelman, Kimberly N Weaver, Xian Zhang, et al.
Inflammatory Bowel Diseases|October 16, 2024
Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel DiseaseArthur J Kastl, Erica J Brenner, Kimberly N Weaver, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2024
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel DiseaseErica J Brenner, Kimberly N Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology|September 17, 2022
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel DiseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
Rheumatology Advances in Practice|December 11, 2024
Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disordersAshley A Darakjian, Mira Bhutani, DeLisa Fairweather, et al.
The Lancet. Gastroenterology & Hepatology|January 20, 2020
Practical guidelines on endoscopic treatment for Crohn's disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease GroupBo Shen, Gursimran Kochhar, Udayakumar Navaneethan, et al.
Crohn'S & Colitis 360|May 9, 2024
Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVEHannah W Fiske, Christopher Ward, Samir A Shah, et al.
The Lancet. Gastroenterology & Hepatology|April 19, 2021
Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease GroupBo Shen, Gursimran S Kochhar, Udayakumar Navaneethan, et al.
The American Journal of Gastroenterology|December 7, 2016
Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled TrialChristopher C Thompson, Barham K Abu Dayyeh, Robert Kushner, et al.
The Lancet. Gastroenterology & Hepatology|November 14, 2021
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch ConsortiumBo Shen, Gursimran S Kochhar, David T Rubin, et al.
Pageof 44

Showing results (421-430 of 432) with videos related to

Sort By:
Pageof 44
The American Journal of Gastroenterology|January 14, 2022
Factors Affecting Initial Humoral Immune Response to SARS-CoV-2 Vaccines Among Patients With Inflammatory Bowel DiseasesMichael D Kappelman, Kimberly N Weaver, Xian Zhang, et al.
Inflammatory Bowel Diseases|October 16, 2024
Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel DiseaseArthur J Kastl, Erica J Brenner, Kimberly N Weaver, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2024
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel DiseaseErica J Brenner, Kimberly N Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology|September 17, 2022
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel DiseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
Rheumatology Advances in Practice|December 11, 2024
Similarities and differences in self-reported symptoms and comorbidities between hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disordersAshley A Darakjian, Mira Bhutani, DeLisa Fairweather, et al.
The Lancet. Gastroenterology & Hepatology|January 20, 2020
Practical guidelines on endoscopic treatment for Crohn's disease strictures: a consensus statement from the Global Interventional Inflammatory Bowel Disease GroupBo Shen, Gursimran Kochhar, Udayakumar Navaneethan, et al.
Crohn'S & Colitis 360|May 9, 2024
Clinical Decision Making in Inflammatory Bowel Disease Mimics: Practice Management from Inflammatory Bowel Disease LIVEHannah W Fiske, Christopher Ward, Samir A Shah, et al.
The Lancet. Gastroenterology & Hepatology|April 19, 2021
Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease GroupBo Shen, Gursimran S Kochhar, Udayakumar Navaneethan, et al.
The American Journal of Gastroenterology|December 7, 2016
Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled TrialChristopher C Thompson, Barham K Abu Dayyeh, Robert Kushner, et al.
The Lancet. Gastroenterology & Hepatology|November 14, 2021
Treatment of pouchitis, Crohn's disease, cuffitis, and other inflammatory disorders of the pouch: consensus guidelines from the International Ileal Pouch ConsortiumBo Shen, Gursimran S Kochhar, David T Rubin, et al.
Pageof 44